跳至主要内容
临床试验/NCT02209415
NCT02209415Unknown不适用

Endoscopic Ultrasound (EUS) and PET-CT Based Follow-up of Patients Radically Resected for Cancer of the Oesophagus, Stomach or Pancreas.

Michael Bau Mortensen2 个研究点 分布在 1 个国家目标入组 182 人开始时间: 2011年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
182
试验地点
2
主要终点
Number of patients eligible for treatment

研究概览

简要总结

Follow-up after successful operative treatment of cancer in the esophagus, stomach or pancreas in order to detect recurrent disease is a controversial topic.

This is because the methods and the consequence of following these patients is unknown.

Therefore the investigators will randomize these patients in to two groups:

  1. One group of patients will be offered visits with a specialist surgeon in a outpatient setting for a clinical evaluation every 3,6,9,12,18 and 24 months after surgery, as is the current standard at our department.
  2. The other group will be offered Endoscopic UltraSound, EUS, and PET/CT with the same intervals as the first group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • R0- resection for primary adenocarcinoma or squamous cell carcinoma of the esophagus, stomach or pancreas.

排除标准

  • 未提供

结局指标

主要结局

Number of patients eligible for treatment

时间窗: 2 years

Does early detection of recurrent disease translate in to more patients being eligible for oncologic treatment?

次要结局

未报告次要终点

研究者

发起方
Michael Bau Mortensen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Michael Bau Mortensen

MD, PhD

Odense University Hospital

研究点 (2)

Loading locations...

相似试验